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Introduction
In the past decades, mankind has produced 
more plastics than ever before, while simultaneous-
ly, due to the stagnation in oil production and the 
general demand for “greener” products, plastics 
from renewable resources have become more and 
more important1,2. Such materials often face signifi-
cant challenges when compared to petrochemical 
plastics, particularly in terms of higher production 
costs and availability of the source materials3,4. 
Whilst competitive costs are still a very important 
factor for the commercial usage of polymers from 
renewable resources, advanced medical applica-
tions, such as tissue repair, polymer-based depots 
for controlled drug release or implants, have paved 
the way for biodegradable as well as biocompatible 
materials. Petroleum-derived products commonly 
cannot meet the requirements inherent to those ap-
plications. In the past years, polyurethanes and de-
rivatives from poly(ethylene glycol) (PEG), which 
used to be the “golden standard” for polymers in 
medical applications, have been continuously re-
placed by different polymers and blends from natu-
ral resources due to their superior biocompatibility 
and biodegradability. Poly(hydroxy alkanoate)s 
(PHAs) (Fig. 1) are one of the new materials that 
have received a lot of attention since their discovery 
in 1926 by Lemoigne5.
Short chain length (scl) PHAs (Table 1) with 
3–5 carbon atoms per repetition unit, and medium 
chain length (mcl) with 6–14 carbon atoms per rep-
etition unit are the two main representatives of the 
PHA congeners. These two types of PHAs differ 
tremendously in their mechanical behavior. Glass 
transition temperatures of scl-PHAs like PHB range 
around 5–10 °C and can be drastically lowered by 
copolymerization with PHV or P4HB (yielding the 
copolymers P(HB-HV) and P(HB-4HB), while mcl-
PHAs have their glass-transition points at lower 
temperatures6,7. While scl-PHAs are brittle and tend 
to have high crystallinity, mcl-PHAs are more flex-
ible, but exhibit a comparably low mechanical 
strength. Especially the brittle behavior of the scl-
PHAs has limited its usage in industrial production.
Blends and copolymers of PHAs have evolved 
into a desired strategy to overcome these shortcom-
ings; this new material class is still under intense 
investigation4. The monomers most commonly con-
sidered in research are listed in Table 1. Apart from 
the investigation of new blends and copolymers, the 
Poly(hydroxy alkanoate)s in Medical Applications
K. P. Luef,a,b F. Stelzer,a and F. Wiesbrockb,*
aGraz University of Technology, Institute for Chemistry and Technology 
of Materials, NAWI Graz, Stremayrgasse 9/V, 8010 Graz, Austria
bPolymer Competence Center Leoben, 
Roseggerstrasse 12, 8700 Leoben, Austria
This review summarizes the state-of-the-art knowledge of the usage of poly(hy-
droxy alkanoate)s in medical and sanitary applications. Depending on the monomers in-
corporated into the polymers and copolymers, this class of polymers exhibits a broad 
range of  (thermo-)plastic properties, enabling their processing by, e.g., solution casting 
or melt extrusion. In this review, strategies for the polymer analogous modification of 
these materials and their surfaces are highlighted and correlated with the potential appli-
cations of the corresponding materials and blends. While the commercial availability of 
purified PHAs is addressed in brief, special focus is put on the (bio-)degradability of 
these polymers and ways to influence the degradation mechanism and/or the duration of 
degradation.
Key words
poly(hydroxy alkanoate), polymer analogous modification, polymer processing, bio-
degradation, medical application
* Corresponding author: frank.wiesbrock@pccl.at
doi: 10.15255/CABEQ.2014.2261
Review 
Received: October 2, 2014 
Accepted: June 1, 2015
F i g .  1  – Generic structural formula of PHAs. The integer m 
typically has the value of 1 (with the exception of 4-hydroxy-
alkanoates such as 4-hydroxybutyrate), the integer n quantifies 
the degree of polymerization.
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investigations of new approaches for the functional-
ization of existing saturated and unsaturated PHAs 
is still a very hot topic8–15. The development of 
PHAs with tailor-made material qualities for direct 
usage in a broad spectrum of applications has be-
come easier to achieve than ever before.
Production
In nature, PHAs are synthesized by a variety of 
different Gram-positive and Gram-negative bacte-
ria. More than 300 different microorganisms that 
are able to synthesize and accumulate PHA intracel-
lularly are known today16. The list includes wild 
type bacteria, such as Cupriavidus necator, Azoto-
bacter species, Pseudomonas species, and Methylo-
bacterium species as well as engineered strains of, 
e.g., Escherichia coli and Cupriavidus necator17–19. 
These types of bacteria synthesize PHA polymers or 
copolymers and store them in the form of granules 
in the cytoplasm. The ability for the cells to grow to 
high cell densities on the one hand, and to accumu-
late a high (total cell mass) percentage of PHA on 
the other, is the key criterion to look for in potential 
production strains. Hence, despite the fact that a 
high number of microorganisms capable of produc-
ing PHAs have been identified, only very few bac-
teria from this list are suited for industrial scale pro-
duction.
Bacteria produce PHAs as storage polymers for 
carbon and energy under metabolism-limited condi-
tions if carbon and energy sources are present, but 
one or more growth-essential nutrients, such as 
phosphate, nitrogen or oxygen are deficient. The 
biosynthesis of PHAs usually occurs with purified 
sugars or edible oils as feedstock, but alternative 
carbon sources, such as whey20, palm oil21, sunflow-
er meal22, and different waste materials23–25 have 
been reported as well. In addition, strategies for the 
production from sugar molasses are under thorough 
investigation3,26,27. The main reason for the on-going 
search for cheap substrates as feedstock originates 
from the challenge to produce PHAs within the 
same range of costs like polyethylene (PE) or poly-
propylene (PP). Alternative carbon sources, more 
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efficient processing and improved production strains 
are fields of active research to overcome this chal-
lenge28.
Cavalheiro et al. showed the possibility of PHB 
production by Cupriavidus necator using waste 
glycerol from the biodiesel industry29. They ob-
served that the specific growth rate peaks with a 
glycerol feed in the range of 20–40 g L–1 due to the 
amounts of sodium still present in the feedstock are 
due to the precedent transesterfication processes.
Khosravi-Darani et al. reported the microbial 
production of PHB from C1 carbon sources such as 
methanol, methane or CO2
30. Although commercial 
PHB production from these carbon sources has not 
yet been established by many companies31, the con-
sideration of using such cheap substrates would be 
very favorable. Mozejko recently showed that sa-
ponified waste palm oil can be used as an attractive 
renewable resource for mcl-PHA synthesis32. With a 
polymer productivity of 57.8 mg L-1 h-1 and a mass 
fraction of PHA in cell dry mass of 43 % of cell dry 
mass CDW after 17 h of fermentation, this method 
proved to be an efficient approach. Muhr et al. re-
ported the usage of fractions of waste lipids from 
animal processing as a feedstock for PHA produc-
tion24, showing that Pseudomonas citronellolis as 
well as Pseudomonas chlororaphis33 are prospective 
candidates for large-scale production of PHA. 
Tanadchangsaeng et al. reported the biosynthesis of 
a statistical copolymer of P(HB-HMV) with up to 
38 mol-% of PHMV34. Cupriavidus necator ex-
pressing the PHA synthase from Pseudomonas spe-
cies was fed with structural analogs that served as 
HMV precursors.
Engineered strains
Apart from the wild type strains of microorgan-
isms such as Cupriavidus necator, there is an on-go-
ing trend to engineer suitable microorganisms to 
produce PHA35. In recent years, a number of strains 
were engineered for PHA accumulation rates of up 
to 90 wt.-% of CDW36. Jeon et al. produced engi-
neered recombinant Ralstonia eutropha strains in a 
manner that the bacteria produced PHAs such as 
statistical P(HB-HHx) copolymers in quantities up 
to 40 wt.-%19. Notably, unrelated carbon sources 
such as glucose, fructose and gluconate were used 
as feedstock. Mifune et al. showed that engineered 
strains of Cupriavidus necator for the production of 
statistical P(HB-HHx) copolymers were able to 
reach over 80 wt.-% of PHA accumulation, using 
soy bean oil as carbon source18. Saika and cowork-
ers recently published results concerning a recombi-
nant E. coli for the production of statistical P(HB-
HMV) copolymers from leucine by expressing 
leucine metabolism-related enzymes derived from 
Clostridium difficile17. Tripathi et al. reported a 
b-oxidation weakened Pseudomonas putida KT2442, 
able to produce a diblock copolymer of the compo-
sition PHB-block-PHHx37. The utilized recombinant 
strain of Pseudomonas putida consists of pha oper-
on and therefore is able to produce mcl-PHA.
Mixed culture approaches
Purified and single strain cultures are by defini-
tion more expensive than the mixed culture ap-
proach, which can also provide the ability to use 
cheaper substrates3. Especially the cheap carbon 
sources of this approach make it an interesting pos-
sibility for an environmentally sustainable PHA 
production system. Fradinho et al. showed that a 
PHA production from individual and mixed volatile 
fatty acids (acetate, propionate, butyrate, lactate, 
malate and citrate) can be achieved38. Only acetate 
and butyrate led to PHB formation, propionate in-
duced the synthesis of statistical P(HB-HV) copoly-
mers. It was postulated that acetate is likely to act 
as a co-substrate for butyrate and propionate uptake, 
since uptake rates of both carbon sources were in-
creased in the presence of acetate. Johnson et al. 
worked on the enrichment of a mixed bacterial cul-
ture with a high PHA storage capacity in order to 
compete with genetically engineered bacteria pro-
ducing PHA from pure substrates like sugars39. 
These optimized processes led to high contents of 
PHA in the cell dry mass and high production rates, 
but expensive substrates, equipment, and high ener-
gy input were required. Within this study, a maxi-
mum PHB content of 89 wt.-% within 7.6 h under 
continuous feeding with acetate was achieved. An-
terrieu et al. showed the integration of biopolymer 
production with process water treatment at a sugar 
factory40. The challenges in these studies were to 
find a way to combine nitrogen removal with PHA 
production.
Processing
The development of new techniques in produc-
tion processing has been a highly active research 
field in recent years41–45. Based on their mechanical 
properties and their (commercial) availability (see 
above), scl-PHAs (homopolymers as well as copo-
lymers) are focused on. Due to the melting points of 
PHP (77 °C) and PHB (175 °C)46, as well as PHV 
(105 °C)47, scl-PHAs and derived copolymers can 
be processed by injection molding, extrusion, extru-
sion bubbles into films and hollow bodies, and fibre 
spinning. While polymer degradation of scl-PHAs 
starts from temperatures only slightly above their 
melting temperatures, namely from approx. 180 °C, 
the processing parameters have to be fine-tuned 
with high precision. For a better understanding of 
the degradation process and potential bottlenecks of 
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the PHA class, several studies were made in the 
last decade32,33. Recently, Hufenus et al. reported 
the fiber melt-spinning of PLA and statistical 
 copolymers of the composition P(HB-HV) for 
the production of new materials for biomedical pur-
poses50. They were able to produce fibers with suit-
able mechanical properties, e.g. tensile strength and 
Young’s modulus to construct a textile fabric (Fig. 
2).
Prior to any processing, PHAs have to be puri-
fied in order to remove bacterial components pres-
ent in the crude polymers – for biomedical applica-
tions, in particular, the bacterial endotoxins have to 
be removed51. Sevastianov et al. reported the impor-
tance of proper endotoxin removal for in-vivo appli-
cations52. Notably, PHAs are most commonly solu-
ble in dichloromethane, chloroform, and 
dichloroethane, although other solvents like ethyl 
acetate or methyl tert-butyl ether have recently been 
investigated as well53,54. Koller et al. reported the 
usage of the “anti-solvent” acetone for the purifica-
tion of scl-PHAs in a novel closed system combin-
ing components for extraction, filtration and prod-
uct work-up, compared to already established 
repeated dissolution-precipitation strategies55,56. By 
designing a new apparatus and optimizing the oper-
ating temperature and pressure control, a method 
was developed that can also be applied to mcl-
PHAs.
Modification
The most common homopolymer PHB, and the 
most common statistical copolymer P(HB-HV), 
have significant shortcomings in terms of brittle-
ness and high degree of crystallinity57. P4HB and 
copolymers containing 4HB are under investigation 
for their mechanical properties for further surgical 
applications58,59. The tensile strength of P4HB is 
close to ultrahigh molecular weight PE and is a very 
flexible material of high strength. However, PHB 
and the statistical copolymer  P(HB-HV) are the 
only PHAs currently available in large scale. 
Post-synthetic and polymer analogous strategies 
were developed in order to overcome the shortcom-
ings of the pristine PHAs.
Combining PHAs with other polymers in the 
form of a blend enables new substance classes with 
modified and tailor-made characteristics, such as 
brittleness, crystallinity, and degradation rates60,61. 
The scl-PHAs, due to their crystallinity, are more 
resistant to biodegradation than mcl-PHAs. By 
blending a different polymer, such as a mcl-PHA 
into the matrix of a scl-PHA, higher degradation 
rates can be achieved while having similar polymer 
properties. Martelli et al. reported the characte-
rization of mcl-PHA-based blends, focusing on 
blends of the statistical copolymer P(HB-HV) and a 
 mcl-PHA composed of PHO, poly(hydroxy deca-
noate), and poly(hydroxy dodecanoate)62. The 
 addition of 5 wt.-% of the mcl-PHA resulted in an 
 increased strain at break of 50 %, compared to 
 non-mo dified statistical copolymers of P(HB-HV).
Wu and colleagues developed a simple and safe 
nanoparticle system by coating P(HB-HHx) (sta-
tistical copolymers) nanoparticles with poly(eth-
ylene imine) for application in in-vitro and ex-vivo 
cellular manipulation. The particles were produced 
from Rhodamine-B-loaded P(HB-HHx) nanoparti-
cles with a diameter of 154 ± 71 nm, which were 
subsequently coated with poly(ethylene imine) in 
order to facilitate the binding to and uptake by 
cells63. A similar strategy for the coating of nanopar-
ticles of statistical copolymers of P(HB-HV) by 
poly(vinyl alcohol) was published by Masood 
et al.64 The particles contained the anti-cancer drug 
Ellipticine. Boyandin et al. reported blends com-
posed of different tropical soils and their influence 
on the biodegradation of PHA homopolymers and 
blends65. Various factors such as differences in soil 
and climatic conditions were found to play a crucial 
role in the degradation. The major degraders of 
PHA could be identified as bacteria of the genera 
Burkholderia, Bacillus, Cupriavidus, Streptomyces, 
Nocardiopsis and Mycobacterium, as well as the 
fungi Gongronella butleri, Penicillium species, 
Acremonium recifei, Purpureocillium lilacinus, and 
Trichoderma pseudokoningii.
Polymer-analogous reactions have particularly 
focused on adding functionality to unsaturated 
PHAs involving the highly reactive double bond of 
the PHA’s side-chains. Reports comprise the car-
boxylation9, hydroxylation10, introduction of amine 
groups11, and combination with other (hydrophilic) 
polymers like PEG12. The polymer-analogous cross-
F i g .  2  – Overlay of light and fluorescence micrographs show-
ing cell adhesion on fibers composed of a PLA core and a coat-
ing of statistical copolymers of P(HB-HV). Reprinted from ref-
erence50 with permission from John Wiley and Sons.
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linking of polymer chains is another strategy aiming 
at the increase of the mechanical strength of PHAs13. 
Rupp et al. reported the UV-induced crosslinking of 
a scl-PHA copolymer, namely films of P(HB-HV), 
with a bisazide capable of absorbing UV light14. By 
addition of up to 3 wt.-% of the bisazide (BA) to 
P(HB-HV), crosslinking degrees of more than 90 % 
could be achieved within irradiation times of less 
than 1 minute. This process was successfully em-
ployed in photolithographic processes that produced 
images with 50 µm resolution (Fig. 3).
The thermally induced crosslinking of biopoly-
esters (comprising PHAs) by telechelic poly(eth-
ylene glycol)-bisazides was summarized in a pat-
ent15, potentially overcoming the long degradation 
rates of pristine PHAs. Recent work by Wu et al. 
focused on the characterization of PHA composites 
that were either chemically crosslinked with cellu-
lose acetate or blended with chestnut shell fibers, 
the latter for enhanced biodegradation66,67. The com-
pounds produced were characterized, among others, 
by biodegradation rates, adhesion of cells, hydro-
philicity and mechanical properties (Fig. 4). The 
results confirm the strategy, since the mechanical 
properties, especially the tensile strength, of both 
composites increased. The biodegradation rate was 
also higher in both composites compared to pure 
PHA, maintaining biocompatibility.
Applications
Certain microorganisms with the ability to pro-
duce PHA depolymerases can promote the biodeg-
radation of PHA. Under aerobic conditions, they are 
degraded into water and carbon dioxide and, under 
anaerobic conditions, into methane and water68. The 
biodegradability and biocompatibility of PHAs 
makes them the ideal candidate for a broad spec-
trum of applications. However, the rates of degrada-
tion are not always suited to the purpose, and de-
pend highly on the microbial environment of the 
PHA product69–73. Corresponding applications of 
PHAs include improved forms of food packaging74, 
waste bags, or agricultural plastics. Sudesh and col-
leagues reported about the synthesis of PHA from 
palm oil and new applications thereof21. In their ap-
proach, they investigated PHA as a potential facial 
oil blotting material as well as a potential dye re-
mover from wastewater.
Recent work from Sridewi et al. showed that 
(blended) PHB-TiO2 electrospun nanocomposite fi-
bers and films (Fig. 5) can be used for the removal 
of dyes, such as malachite green via decolorization, 
degradation, and detoxification75. Materials derived 
from the fiber melt-spinning of PLA and P(HB-HV) 
(reported by Hufenus et al., see above)50, were sub-
F i g .  3  – Top: Crosslinking of polymer chains with a bisazide 
(BA) under UV irradiation. Bottom: Multi-step photolithographic 
processes based on P(HB-HV). Reproduced in part from refer-
ence14 with permission of The Royal Society of Chemistry.
F i g .  4  – SEM images of the morphology of PHA composites 
after 0, 60, and 120 days of degradation. A-C: pristine PHA, 
D-F: PHA crosslinked with cellulose actetate, G-I: PHA grafted 
on acrylic acid/cellulose acetate. Biodegradation by Aceto-
bacter pasteurianus can be monitored by the erosion in the films. 
Reprinted from reference66 with permission from Elsevier.
F i g .  5  – SEM micrographs showing the morphological fea-
tures of electrospun fibers (left) and spincast films (right) of 
PHB blended with TiO2. Reprinted from reference
75 with per-
mission from Hindawi Publishing Corporation.
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jected to biodegradability studies on human fibro-
blasts that revealed no toxicity of the fibers and 
cells proliferated well under the condition provided 
by these new materials. Additionally, the molecular 
weight loss caused by biodegradation of the fibers 
reduced the tensile strength up to 33 % after 4 
weeks of incubation, further proving the promise of 
this new material in medical applications.
Castro-Mayorga et al. showed the stabilization 
of antimicrobial silver nanoparticles (preventing 
their agglomeration) by a PHA obtained from mixed 
bacterial culture74. The study demonstrated that un-
purified statistical copolymers of P(HB-HV) can be 
used as capping agent that helps prevent agglomer-
ation.
The area most considered for possible applica-
tion of PHAs and PHA blends is the area of medical 
applications1,8,58,76–84. The usage as a system for drug 
delivery is perhaps the longest investigated applica-
tion in this area, but still a highly active field85,86. 
Naveen et al. synthesized nanofibers mats of PHB 
by electrospinning and loaded them with Kanamy-
cin sulphate to test against Staphylococcus aureus. 
The drug release of the antibiotic showed more than 
95 % release within 8 hours84. Xiong and colleagues 
prepared nanoparticles of PHB, statistical copoly-
mers of P(HB-HHx) and PLA and loaded them with 
lipid-soluble colorant rhodamine B isothiocyanate 
as a model compound87. Due to their size, nanopar-
ticles can penetrate deeply into tissue material and 
are more efficiently taken up by cells. They achieved 
a high loading efficiency of around 75 % with the 
PHB homo- and P(HB-HHx) statistical copolymers, 
and a drug release over a period of at least 20 days, 
while reference PLA nanoparticles only lasted 15 
days. Chaturvedi et al. used blends of PHB with 
cellulose acetate phthalate (CAP) in different com-
positions for drug loading with 5-fluorouracil, an 
anticancer drug, and investigated the simulated co-
lon delivery of the said drug88. The pH-sensitive 
property of the blend caused a higher in vitro re-
lease at alkaline pH than at acidic pH, suggesting its 
potential for colon delivery.
Tissue repair has become one of the major 
fields when combining PHA with medical applica-
tions77,81,83,89. The high biocompatibility of PHB, 
which is not surprising when considering the natu-
ral occurrence of 3HB in the blood stream1, makes 
it an ideal candidate for scaffolds, which can later 
be used for the repair of tissue damage. Results of 
animal testing clearly showed the high biocompati-
bility of implants of PHB and P(HB-HV) statistical 
copolymers. Shishatskaya et al. and Volova et al. 
investigated the physiological and biochemical 
characteristics of Wistar rats implanted with PHA 
sutures. Long-term (1 year) observations showed 
that the animals with PHB or P(HB-HV) threads 
were active and healthy throughout the experiment, 
and suggested that the implanted polymer threads 
did not affect the organism in a negative way56,90. 
For biodegradable implants, the high crystallinity is 
indeed a problem, rendering the attack of degrading 
enzymes more difficult91. Various blends of differ-
ent PHAs, such as P(HB-HV), are therefore under 
investigation, combining the excellent biocompati-
bility of PHB with a lower degree of crystallinity 
provided by the incorporated PHV89.
Basnett et al. reported novel blends composed 
of PHO and PHB for medical applications. In their 
study, blends with various ratios of PHB and PHO 
in various ratios were created, and degradation as 
well as biocompatibility tests were carried out92. 
The degradation found in these blends occurred via 
surface erosion and not bulk degradation, which 
would lead to a more controlled degradation, while 
still maintaining the core structure. Combined with 
an increased biocompatibility with HMEC-1 cells, 
these blends showed a very promising perspective 
for the development of biodegradable materials.
Another strategy for tissue repair was reported 
by Ellis and colleagues who produced laser-perfo-
rated biodegradable PHA scaffold films93. The pores 
of the films of statistical copolymers of P(HB-HV) 
exhibited micrometer dimensions. Hence, once the 
cells were seeded onto the film surface, they could 
attach and proliferate on the upper surface as well 
as through the pores and into the region of the dam-
aged tissue. In their study, they achieved an in-
creased surface amorphicity at the pore edges, 
which may facilitate cell adhesion and could pro-
mote growth and migration of cells for regenerative 
medicine.
Sutures of PHB and P(HB-HV), respectively, 
were found to exhibit the mechanical strength re-
quired for use in muscle-facial wounds, and, hence, 
they were tested on animals intramuscularly90. The 
environmental tissue reacted to the PHAs by a tran-
sient post-traumatic inflammation, as well as in the 
formation of fibrous capsules with a thickness of up 
to 200 μm, which thinned upon prolonged expo-
sure. If the sutures were implanted for periods of up 
to one year, they stimulated no suppurative inflam-
mation or necrosis.
On the topic of nerve injury repair, a new strat-
egy provided by Wang et al. described the usage of 
PHA as scaffolds for human bone marrow stromal 
cells94. A statistical terpolyester of the composition 
P(HB-HV-HHx) was compared with poly(lactic 
acid) and P(HB-HHx) for their function in differen-
tiating the human bone marrow stromal cells into 
nerve cells. It could be shown that the terpolyester 
had stronger cell adhesion, proliferation and differ-
entiation than the other two polymers. Three-di-
mensional scaffolds of a composite composed of 
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P(HB-HHx) and mesoporous bioactive glass (in dif-
ferent mass ratios) were printed with a 3D bioplot-
ter by the group of Zhao et al., aiming at the deliv-
ery of materials for enhanced bone regeneration95. 
These highly porous, yet robust scaffolds showed 
good bioactivity, stimulated human bone marrow 
stromal cells adhesion and stimulated bone regener-
ation in in-vivo experiments (Fig. 6).
Conclusions and outlook
New technologies and evolution of production 
modes (batch, feed batch, continuous) methods 
have allowed PHAs to become a recognizable play-
er in the field of biodegradable polymers. Research 
in biotechnology and strain engineering has enabled 
the production of PHAs from cheap substrates, in-
line with existing processing facilities such as waste 
treatment and easier-to-handle microorganisms 
compared to the wild type production strains report-
ed in the past. Continuous improvements of PHA 
contents within the cells and growth rates are re-
ported on a regular basis.
PHAs are still far from joining the competitive 
level of production costs compared to petro-
leum-based polymers such as PP or PE. Hence, cur-
rently, PHAs can be only considered for advanced 
applications, in which they cannot be replaced by 
petroleum-based polymers. Correspondingly, PHAs 
are well-suited for any application that requires bio-
compatibility and/or biodegradability of the poly-
mer. Notably, purity requirements are high for such 
applications, and the removal of impurities, such as 
endotoxins, further increases the production costs. 
For medical applications, in particular the ho-
mopolymers PHB and PHV as well as the statistical 
copolymer PHB-stat-PHV have been investigated. 
These so-called scl-PHAs can be processed by melt 
processes as they are thermoplasts, or by solution 
processes due to their solubility in (a limited num-
ber of) organic solvents.
In order to adapt the polymers’ properties to the 
specific application details and requirements, sever-
al techniques can be applied to PHAs, not to men-
tion the blending with other (biodegradable and 
 biocompatible) polymers, and polymer-analogous 
modification by, e.g., crosslinking as prominent 
 examples. Using these techniques, a broad spectrum 
of tailor-made mechanical and physical properties 
can be realized. In the area of medical applications, 
in particular tissue engineering could benefit from 
these recent developments and improvements. PHA 
blends as scaffolds for tissue repair are a highly ac-
tive research area that has produced a lot of very 
promising results from in-vivo tests in recent years.
PHAs, quo vadis? Facing the need for advanced 
and/or alternative medical devices for tissue engineer-
ing, drug delivery, and implants in their broadest sense 
on the one hand, and the promising research results in 
recent years, the applicability of PHAs in those medi-
cal areas is more than plausible in the near future.
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